Inovio Pharmaceuticals (INO) Posts Narrwer than Expected Q4 Loss; Revs Light

Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.1 million.

For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Aon names interim CFO as Edmund Reese exits the firm
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance